‘Only Owlet’ shows the impact stress & lack
of sleep are having on the lives of parents globally and shares
powerful stories from those who have found a solution
Today, Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the
pioneer of smart infant monitoring, launched Only Owlet, a global
campaign that brings together new research and real-life stories to
spotlight the common anxieties parents all experience, and how
Owlet helps empower families around the world by helping them
through the most difficult of challenges.
Parents Around the World Are Exhausted And Anxious
Owlet is sharing new data completed in conjunction with
accredited research firm Censuswide, revealing the extent of the
stress and worry that comes with being a new parent, and what
parents need to alleviate these anxieties. The data shows that the
top emotion felt by parents during the first year of their baby’s
life is exhaustion – and rightfully so as parents are getting up to
check on their baby up to eight times each night. Parents are
anxious about their baby getting sick or passing away from sudden
unexpected infant death syndrome/sudden infant death syndrome
(SUIDS/SIDS), and caregivers around the globe are struggling with
sleep deprivation, anxiety, and finding time for themselves.
Owlet Parents Have More Peace Of Mind
Almost 3 out of 4 of parents surveyed say that infant monitoring
technology has helped them feel less stressed and anxious. Owlet is
the answer for millions of parents across the globe. For more than
a decade, Owlet has been at the forefront of technology development
that empowers parents when it comes to their baby’s health. As the
first company in the baby monitoring industry to have global
medical certifications, including two FDA-clearances, Owlet
provides caregivers with their baby’s live health vitals and sends
real-time, actionable alarms allowing parents to rest easier while
their baby sleeps or intervene in potentially critical events. In
fact, 96% of Owlet parents surveyed have reported more peace of
mind and 94% have reported better quality of sleep1.
“Owlet’s mission is to empower caregivers with critical
information, so that they can take quick action on their babies’
health, or just feel confident their baby is safe while they
sleep,” said Kurt Workman, Owlet Chief Executive Officer and
Co-Founder. “It’s clear from the data that parents around the world
are in desperate need of sleep and peace of mind. Our Owlet parent
stories demonstrate that health monitoring technology is impactful
and very necessary.”
Real Stories, Real Impact
Kali is the mother of a 5-month-old, and an Owlet parent, who
brought her baby home after a five day stay in the neonatal
intensive care unit (NICU) due to fluid in his lungs. “During this
two month period, my anxiety was through the roof. Constantly
checking his chest, manually counting his respirations and pulse. I
decided to get my hands on the Dream Sock. The very first night we
used it I noticed the weight of my stress felt so much lighter.”
Another parent, Brian, shared his story about how Owlet helped him
know when to seek care for his baby. “We thought she just had a
cold, but our Dream Sock notified us of her low oxygen, prompting
us to take her to the hospital. We were informed that [she] had RSV
[respiratory syncytial virus] and was admitted immediately. Without
that knowledge, who knows how long we would have waited to bring
her in.”
Whether it was receiving an alarm that prompted them to take
immediate action, helping parents identify early signs of illness,
or simply providing the peace of mind that helped them get back to
sleep, hundreds of parents around the world have shared how Owlet
has made a critical difference in their lives.
“The Only Owlet campaign is aimed at sharing stories like Kali
and Brian’s with other parents, so that they can feel empowerment
and community in their shared experiences,” said Liz Teran, Chief
Marketing Officer at Owlet. “We invite all parents to share their
stories with us. But most importantly, our goal is to give parents
confidence in their baby’s safety and a solution for their worries,
so that they can focus on enjoying the earliest and most
challenging days of parenthood.”
To see how Owlet has been there for other families, or to share
your own story, visit www.owletcare.com/pages/why-owlet.
Survey Methodology & Additional References
The total sample size was 3,012 parents (16+) with children aged
1 and under across Germany, the U.K. and the U.S. The research was
conducted from 06.13.2024 – 06.18.2024. Censuswide abides by and
employs members of the Market Research Society which is based on
the ESOMAR principles. Regional data for the U.S., U.K and German
markets can be made available. Please contact owlet@diffusionpr.com
for more information.
1. Reducing Caregiver Stress From At-Home Infant Monitoring:
Results from a survey of Owlet Sock user experiences. Lehi, Utah:
Owlet Baby Care, Inc.
About Owlet, Inc.
Owlet’s digital health infant monitoring platform is
transforming the journey of parenting. Owlet, Inc. (NYSE:OWLT), a
small-cap healthcare growth equity, offers FDA-authorized medical
and consumer pediatric wearables and an integrated HD visual and
audio camera that provide real-time data and insights to parents
who safeguard health, optimize wellness, and ensure peaceful sleep,
for their children.
Since 2012, over 2 million parents worldwide have used Owlet’s
platform contributing to one of the largest collections of consumer
infant health and sleep data. The Company continues to develop
software and digital data solutions to bridge the current
healthcare gap between hospital and home and bring new insights to
parents and caregivers globally. Owlet believes that every child
deserves to live a long, happy, and healthy life. To learn more,
visit www.owletcare.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. We intend such forward-looking statements to be covered by
the safe harbor provisions for forward-looking statements contained
in Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. All
statements contained in this press release that do not relate to
matters of historical fact should be considered forward-looking
statements, including, without limitation, statements regarding the
Company’s potential global reach and its devices’ expected
efficacy. In some cases, you can identify forward-looking
statements by terms such as “estimate,” “may,” “believes,” “plans,”
“expects,” “anticipates,” “intends,” “goal,” “potential,”
“upcoming,” “outlook,” “guidance,” “can,” the negation thereof, or
similar expressions, although not all forward-looking statements
contain these identifying words. Forward-looking statements are
based on the Company’s expectations at the time such statements are
made, speak only as of the dates they are made and are susceptible
to a number of risks, uncertainties and other factors. The
Company’s actual results, performance or achievements may differ
materially from any future results, performance or achievements
expressed or implied by our forward-looking statements. Many
important factors could affect the Company’s future results and
cause those results to differ materially from those expressed in or
implied by the Company’s forward-looking statements. Such factors
include, but are not limited to, (i) the regulatory pathway for
Owlet’s products, including submissions to, actions taken by and
decisions and responses from regulators, such as the FDA and
similar regulators outside of the United States, as well as Owlet’s
ability to obtain and maintain regulatory approval or certification
for our products and other regulatory requirements and legal
proceedings; (ii) Owlet’s competition and the Company’s ability to
profitably grow and manage growth; (iii) the Company’s ability to
enhance future operating and financial results or obtain additional
financing to continue as a going concern; (iv) Owlet’s ability to
obtain additional financing in the future, as well as risks
associated with the Company’s current loan and debt agreements,
including compliance with debt covenants, restrictions on the
Company’s access to capital, the impact of the Company’s overall
debt levels and the Company’s ability to generate sufficient future
cash flows to meet Owlet’s debt service obligations and operate
Owlet’s business; (v) the ability of Owlet to implement strategic
initiatives, reduce costs, grow revenues, develop and launch new
products, innovate and enhance existing products, meet customer
demands and adapt to changes in consumer preferences and retail
trends; (vi) Owlet’s ability to acquire, defend and protect its
intellectual property and satisfy regulatory requirements,
including but not limited to requirements concerning privacy and
data protection, breaches and loss, as well as other risks
associated with Owlet’s digital platforms and technologies; (vii)
Owlet’s ability to maintain relationships with customers,
manufacturers and suppliers and retain Owlet’s management and key
employees; (viii) Owlet’s ability to upgrade and maintain its
information technology systems; (ix) changes in applicable laws or
regulations; (x) the impact of and disruption to Owlet’s business,
financial condition, operations, supply chain and logistics due to
economic and other conditions beyond the Company’s control, such as
health epidemics or pandemics, macro-economic uncertainties, social
unrest, hostilities, natural disasters or other catastrophic
events; (xi) the possibility that Owlet may be adversely affected
by other economic, business, regulatory, competitive or other
factors, such as changes in discretionary consumer spending and
consumer preferences; and (xii) other risks and uncertainties set
forth in the Company’s other releases, public statements and
filings with the U.S. Securities and Exchange Commission (the
“SEC”), including those identified in the “Risk Factors” section of
the Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2023, as updated in the Company’s Quarterly Report on
Form 10-Q for the quarterly period ended March 31, 2024 and as any
such factors may be updated from time to time in the Company’s
other filings with the SEC. All such forward-looking statements
attributable to the Company or any person acting on the Company’s
behalf are expressly qualified in their entirety by the cautionary
statements contained or referred to above. Moreover, the Company
operates in an evolving environment. Except as required by law, the
Company assumes no obligation to update any forward-looking
statements after the date of this press release, whether because of
new information, future events or otherwise, although Owlet may do
so from time to time.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240725731305/en/
Media: pr@owletcare.com owlet@diffusionpr.com
Grafico Azioni Sandbridge Aquisition (NYSE:OWLT)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Sandbridge Aquisition (NYSE:OWLT)
Storico
Da Gen 2024 a Gen 2025
